NFLX vs. BMY
NFLX (Netflix, Inc.) and BMY (Bristol-Myers Squibb Company) are both stocks. NFLX operates in Entertainment (Communication Services), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, NFLX returned 23.46%/yr vs 0.92%/yr for BMY. At a 0.16 correlation, their price movements are largely independent.
Performance
NFLX vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NFLX achieves a -12.35% return, which is significantly lower than BMY's 8.54% return. Over the past 10 years, NFLX has outperformed BMY with an annualized return of 23.46%, while BMY has yielded a comparatively lower 0.92% annualized return.
NFLX
- 1D
- 0.76%
- 1M
- -6.90%
- YTD
- -12.35%
- 6M
- -18.02%
- 1Y
- -34.28%
- 3Y*
- 27.20%
- 5Y*
- 10.68%
- 10Y*
- 23.46%
BMY
- 1D
- 1.18%
- 1M
- 1.20%
- YTD
- 8.54%
- 6M
- 12.26%
- 1Y
- 25.69%
- 3Y*
- 0.16%
- 5Y*
- 1.52%
- 10Y*
- 0.92%
NFLX vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NFLX Netflix, Inc. | -12.35% | 5.19% | 83.07% | 65.11% | -51.05% | 11.41% | 67.11% | 20.89% | 39.44% | 55.06% |
BMY Bristol-Myers Squibb Company | 8.54% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between NFLX and BMY is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since May 24, 2002 | 0.16 |
The correlation between NFLX and BMY shifts across timeframes, from -0.01 (3 years) to 0.16 (all time), reflecting how their relationship changes across market environments.
Fundamentals
NFLX:
$353.25B
BMY:
$117.03B
NFLX:
$3.09
BMY:
$3.57
NFLX:
26.58
BMY:
16.06
NFLX:
1.05
BMY:
0.92
NFLX:
7.58
BMY:
2.41
NFLX:
11.35
BMY:
5.83
NFLX:
$46.89B
BMY:
$48.48B
NFLX:
$22.99B
BMY:
$33.33B
NFLX:
$26.91B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NFLX vs. BMY — Risk / Return Rank
NFLX
BMY
NFLX vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Netflix, Inc. (NFLX) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NFLX | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.00 | ||
| Sortino ratioReturn per unit of downside risk | -3.03 | ||
| Omega ratioGain probability vs. loss probability | 0.81 | 1.18 | -0.37 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | 1.89 | -2.68 |
| Martin ratioReturn relative to average drawdown | -1.40 | 4.15 | -5.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NFLX | BMY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.04 | 0.96 | -2.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.25 | 0.06 | +0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.04 | +0.53 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | 0.35 | +0.23 |
Drawdowns
NFLX vs. BMY - Drawdown Comparison
The maximum NFLX drawdown since its inception was -81.99%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for NFLX and BMY.
Loading charts...
Drawdown Indicators
| NFLX | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.99% | -72.03% | -9.96% |
Max Drawdown (1Y)Largest decline over 1 year | -43.35% | -13.68% | -29.67% |
Max Drawdown (3Y)Largest decline over 3 years | -43.35% | -36.85% | -6.50% |
Max Drawdown (5Y)Largest decline over 5 years | -75.95% | -47.67% | -28.28% |
Max Drawdown (10Y)Largest decline over 10 years | -75.95% | -47.67% | -28.28% |
Current DrawdownCurrent decline from peak | -38.63% | -17.59% | -21.04% |
Average DrawdownAverage peak-to-trough decline | -24.90% | -22.38% | -2.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.59% | 6.21% | +18.38% |
Volatility
NFLX vs. BMY - Volatility Comparison
The current volatility for Netflix, Inc. (NFLX) is 6.59%, while Bristol-Myers Squibb Company (BMY) has a volatility of 7.08%. This indicates that NFLX experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NFLX | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.59% | 7.08% | -0.49% |
Volatility (6M)Calculated over the trailing 6-month period | 25.21% | 17.90% | +7.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.09% | 26.83% | +6.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.09% | 24.02% | +19.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.51% | 25.25% | +16.26% |
Dividends
NFLX vs. BMY - Dividend Comparison
NFLX has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.37%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.37% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
NFLX Netflix, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NFLX vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Netflix, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NFLX vs. BMY - Profitability Comparison
NFLX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Netflix, Inc. reported a gross profit of 6.36B and revenue of 12.25B. Therefore, the gross margin over that period was 51.9%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
NFLX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Netflix, Inc. reported an operating income of 3.96B and revenue of 12.25B, resulting in an operating margin of 32.3%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
NFLX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Netflix, Inc. reported a net income of 5.28B and revenue of 12.25B, resulting in a net margin of 43.1%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
NFLX and BMY have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMY has higher volatility (7.08%) compared to NFLX (6.59%). In terms of maximum drawdown, NFLX dropped -81.99% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (0.96 vs -1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NFLX and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer